Literature DB >> 25323262

Thoracic aortic aneurysm and dissection.

Judith Z Goldfinger1, Jonathan L Halperin1, Michael L Marin2, Allan S Stewart3, Kim A Eagle4, Valentin Fuster5.   

Abstract

Aortic dissection is the most devastating complication of thoracic aortic disease. In the more than 250 years since thoracic aortic dissection was first described, much has been learned about diseases of the thoracic aorta. In this review, we describe normal thoracic aortic size; risk factors for dissection, including genetic and inflammatory conditions; the underpinnings of genetic diseases associated with aneurysm and dissection, including Marfan syndrome and the role of transforming growth factor beta signaling; data on the role for medical therapies in aneurysmal disease, including beta-blockers, angiotensin receptor blockers, and angiotensin-converting enzyme inhibitors; prophylactic surgery for aneurysm; surgical techniques for the aortic root; and surgical and endovascular management of aneurysm and dissection for different aortic segments.
Copyright © 2014 American College of Cardiology Foundation. Published by Elsevier Inc. All rights reserved.

Entities:  

Keywords:  Marfan syndrome; aortic aneurysm; cardiac surgical procedures; endovascular procedures; risk factors; transforming growth factor beta

Mesh:

Year:  2014        PMID: 25323262     DOI: 10.1016/j.jacc.2014.08.025

Source DB:  PubMed          Journal:  J Am Coll Cardiol        ISSN: 0735-1097            Impact factor:   24.094


  88 in total

1.  Standing tall after DeBakey Type I aortic dissection extending to left iliac artery.

Authors:  Deepak Natarajan; Nalin Natarajan
Journal:  Indian Heart J       Date:  2015-09-11

2.  Sudden cardiac death from aortoesophageal fistula: an autopsy case report of a rare complication of thoracic aortic aneurysm.

Authors:  Daniel Chan; Chris O'Donnell; Sarah Parsons
Journal:  Forensic Sci Med Pathol       Date:  2017-08-14       Impact factor: 2.007

Review 3.  Molecular pathogenesis of genetic and sporadic aortic aneurysms and dissections.

Authors:  Ying H Shen; Scott A LeMaire
Journal:  Curr Probl Surg       Date:  2017-02-03       Impact factor: 1.909

Review 4.  Acute Aortic Syndromes: Diagnosis and Treatment.

Authors:  Michael C Murphy; Catherine F Castner; Nicholas T Kouchoukos
Journal:  Mo Med       Date:  2017 Nov-Dec

5.  Lineage-specific events underlie aortic root aneurysm pathogenesis in Loeys-Dietz syndrome.

Authors:  Elena Gallo MacFarlane; Sarah J Parker; Joseph Y Shin; Benjamin E Kang; Shira G Ziegler; Tyler J Creamer; Rustam Bagirzadeh; Djahida Bedja; Yichun Chen; Juan F Calderon; Katherine Weissler; Pamela A Frischmeyer-Guerrerio; Mark E Lindsay; Jennifer P Habashi; Harry C Dietz
Journal:  J Clin Invest       Date:  2019-01-07       Impact factor: 14.808

Review 6.  Epigenetic influences on genetically triggered thoracic aortic aneurysm.

Authors:  Stefanie S Portelli; Elizabeth N Robertson; Cassandra Malecki; Kiersten A Liddy; Brett D Hambly; Richmond W Jeremy
Journal:  Biophys Rev       Date:  2018-09-28

Review 7.  Diagnostic approach and management of genetic aortopathies.

Authors:  Rohan Bhandari; Rajani D Aatre; Yogendra Kanthi
Journal:  Vasc Med       Date:  2020-02       Impact factor: 3.239

8.  KIF6 719Arg Genetic Variant and Risk for Thoracic Aortic Dissection.

Authors:  Olga A Iakoubova; Carmen H Tong; Joseph Catanese; Charles M Rowland; May M Luke; Maryann Tranquilli; John A Elefteriades
Journal:  Aorta (Stamford)       Date:  2016-06-01

9.  Analysis of the contribution of 129 candidate genes to thoracic aortic aneurysm or dissection of a mixed cohort of sporadic and familial cases in South China.

Authors:  Ying Li; Miaoxian Fang; Jue Yang; Changjiang Yu; Juntao Kuang; Tucheng Sun; Ruixin Fan
Journal:  Am J Transl Res       Date:  2021-05-15       Impact factor: 4.060

10.  Acute Myocardial Infarction and Concomitant Stroke as the Manifestations in a Patient with Type A Aortic Dissection: A Case Report with Three Years of Follow-Up.

Authors:  Po-Jung Yuan; Wai-Kin Wong
Journal:  Acta Cardiol Sin       Date:  2018-01       Impact factor: 2.672

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.